Bicara Therapeutics (BCAX) Times Interest Earned (2023 - 2026)
Bicara Therapeutics' (BCAX) quarterly Times Interest Earned came in at -$0.55 in Q1 2026, up 99.87% year-on-year from -$0.28 in Q1 2025, and up 99.87% quarter-over-quarter from -$411.22 in Q4 2025.
Bicara Therapeutics (BCAX) Times Interest Earned (2023 - 2026) Analysis & Trends
Bicara Therapeutics' Times Interest Earned history runs 4 years deep, the most recent figure standing at -$0.55 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 99.87% year-over-year to -$0.55 in Q1 2026; TTM through Mar 2026 was -$1.6, a 99.56% increase from a year earlier, with the FY2025 full-year figure at -$1.59, down 13.99% from the prior year.
- Times Interest Earned climbed to -$0.55 in Q1 2026 per BCAX's latest filing, from -$411.22 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.55 in Q1 2026 and bottomed at -$1710.9 in Q4 2023.
- The 4-year median for Times Interest Earned is -$336.56 (2024), against an average of -$427.69.
- Across the five-year window, Times Interest Earned slumped 97.19% in 2025 and soared 99.87% in 2026, its largest moves.
- Year by year, Times Interest Earned stood at -$1710.9 in 2023, then jumped by 84.43% to -$266.37 in 2024, then plunged by 54.38% to -$411.22 in 2025, then surged by 99.87% to -$0.55 in 2026.
- Per Business Quant, the three latest BCAX Times Interest Earned figures stand at -$0.55 (Q1 2026), -$411.22 (Q4 2025), and -$406.76 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Bicara Therapeutics | 1.64 Bn | 1.64 Bn | - | -0.55 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.55 |
| Dec 31, 2025 | -411.22 |
| Sep 30, 2025 | -406.76 |
| Jun 30, 2025 | -1.56 |
| Mar 31, 2025 | -417.88 |
| Dec 31, 2024 | -266.37 |
| Sep 30, 2024 | -206.28 |
| Dec 31, 2023 | -1,710.88 |